Some barriers challenging our efforts to improve the lives of cancer patients and their families are too complex for any one organization to address on its own. To overcome these barriers, the American Cancer Society (ACS) unites organizations in collaborative partnerships through its mission-critical national roundtables. Currently, we provide organizational leadership and expert staff support to roundtables focused on breast cancer, cervical cancer, colorectal cancer, lung cancer, HPV vaccination, and patient navigation.

What is a roundtable?

An ACS roundtable is an organization of organizations dedicated to a shared vision of giving all people a fair and just opportunity to prevent and survive cancer. The ACS roundtables are a recommended and proven model for creating sustained partnerships across diverse sectors to tackle the most complex problems in cancer.

ACS, in partnership with the Centers for Disease Control and Prevention (CDC), launched its first roundtable, the National Colorectal Cancer Roundtable (NCCRT), in 1997. Since then, we have worked with partners to establish the National HPV Vaccination Roundtable, the National Lung Cancer Roundtable (NLCRT), and the National Navigation Roundtable (NNRT). In 2022, we will launch two new roundtables focusing on breast cancer and cervical cancer.

National Colorectal Cancer Roundtable

In 1997, the ACS, in collaboration with the CDC, launched the National Colorectal Cancer Roundtable (NCCRT) with the sole aim of increasing the proportion of eligible US residents who are up to date with high-quality colorectal cancer screening. The NCCRT is comprised of over 150 member organizations, with nationally known experts, thought leaders, and decision-makers on CRC screening policy and delivery serving as member representatives. 

The combined energy of the members of the NCCRT has become one of nation’s most important catalysts to increase CRC screening rates. In 2019, the NCCRT launched 80% in Every Community, a health equity-focused campaign to improve colorectal cancer screening across the nation. This initiative builds on the award-winning and high-achieving 80% by 2018, where more than 1,800 organizations pledged to strive toward reaching screening rates of 80% or higher for age-eligible adults. 

The current activities of the NCCRT and its partners are guided by the 80% in Every Community Strategic Plan, and progress toward those planned activities are monitored and discussed at the NCCRT Annual Meeting and through the regular meetings of its strategic priority teams.  


National HPV Vaccination Roundtable

The National HPV Vaccination Roundtable is a coalition of 70+ organizations working at the intersection of immunization and cancer control to prevent HPV cancers and work towards the elimination of HPV disease as a public health problem.

Founded by ACS and the CDC in 2014, the HPV Roundtable’s power comes from passionate advocates representing survivors, researchers, health systems, providers, and public health leaders among others. Members contribute expertise and activate their own organizations to advance our collective mission.

The HPV Roundtable members advance their mission by: 

  • Convening national organizations, experts, and key stakeholders to ideate, strategize, and problem solve.
  • Communicating and informing key audiences (coalitions, health systems, parents, providers, and the public) about the importance of HPV vaccination as cancer prevention.
  • Catalyzing members, and by extension the public, to take action to close the adolescent vaccination gap.

The HPV Roundtable regularly holds a national meeting of its members to align key stakeholders and audiences, and improve member coordination around the group’s annual action plan.


National Lung Cancer Roundtable

The National Lung Cancer Roundtable (NLCRT) was formally launched in 2017, and since that time, has brought together and galvanized more than 170 leading organizations, professional societies, government agencies, cancer centers, academic institutions, and health plans to help to reduce lung cancer mortality. The mission of the NLCRT is to create lung cancer survivors and to lower the impact of lung cancer through risk reduction, early detection, and assurance of optimal diagnosis and therapy.  

The NLCRT is a supportive platform for harnessing and coordinating the collective power and expertise of the entire lung cancer community. The NLCRT works to ensure high-quality access to the continuum of care for all adults at risk for, or affected by, lung cancer with particular attention to where disparities exist by sex, race, ethnicity, income, insurance status, and geography. 

A collaboratively developed strategic plan as well as direction from a multidisciplinary Steering Committee guides the shared efforts of the NLCRT. Task groups develop and manage projects that fall into their scope of work along the lung cancer continuum. The full membership gathers annually to track progress, understand emerging trends, and accelerate new roundtable activities.


National Navigation Roundtable 

The American Cancer Society (ACS) launched the National Navigation Roundtable (NNRT) in 2017. The NNRT is a national coalition of organizations and invited individuals dedicated to advancing navigation efforts that eliminate barriers to quality care, reduce disparities, and foster ongoing health equity across the cancer continuum. The ultimate vision of the NNRT is high-quality cancer care for all through evidence-based patient navigation.

Together, NNRT members address the needs in the field of navigation that are best tackled through collective action and support. Through its annual meeting and task groups, the NNRT builds evidence of the positive impact of patient navigation across the cancer continuum.